image
Aclaris Therapeutics, Inc. ACRS
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 1.28
-1.56 %
$ 139 M
Market Cap
-0.75
P/E
BALANCE SHEET
220 M ASSETS
11.61%
Growth Rates
1Year 11.61%
3Years -4.28%
5Years 17.52%
7Years -1.42%
10Years 28.92%
64.8 M LIABILITIES
61.02%
Growth Rates
1Year 61.02%
3Years 6.34%
5Years 17.94%
7Years 19.84%
10Years 5.44%
156 M EQUITY
-1.03%
Growth Rates
1Year -1.03%
3Years -7.62%
5Years 17.35%
7Years -5.15%
10Years 25.24%
BALANCE SHEET DECOMPOSITION
Balance Sheet Aclaris Therapeutics, Inc.
image
Current Assets 126 M
Cash & Short-Term Investments 114 M
Receivables 318 K
Other Current Assets 12 M
Non-Current Assets 94.4 M
Long-Term Investments 90.3 M
PP&E 1.01 M
Other Non-Current Assets 3.07 M
51.56 %5.46 %40.99 %Total Assets$220.3m
Current Liabilities 31.6 M
Accounts Payable 4.69 M
Short-Term Debt 0
Other Current Liabilities 26.9 M
Non-Current Liabilities 33.2 M
Long-Term Debt 0
Other Non-Current Liabilities 33.2 M
7.24 %41.54 %51.22 %Total Liabilities$64.8m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 24.6 39.9 45.3 27.3 54.1 35.9 57.0 208.9 30.2 9.9 10.8 9.6
Short Term Investments 89.0 79.2 172.3 164.1 32.1 39.1 111.0 173.7 107.1 75.0 5.4 3.7
Receivables 0.3 0.3 0.5 0.6 0.8 0.7 0.6 0.5 0 0 0 0
Inventory 0 0 (12.2) (34.2) 0 5.0 0.8 (6.4) 0 0 0 0
Other Current Assets 12.0 9.5 13.5 26.0 5.2 9.8 10.2 9.8 2.7 3.1 0.2 62 K
Total Current Assets 126.0 128.9 231.6 205.0 57.5 83.8 179.5 208.9 174.1 92.0 16.3 13.4
PP&E 1.0 1.6 1.1 1.3 1.7 2.5 4.3 2.2 0.5 0.4 0.5 19 K
Intangible Assets 0 0.3 7.0 7.0 7.1 7.2 73.0 7.3 0 0 0 0
Goodwill 0 0 0 0 0 0 18.5 18.5 0 0 0 0
Long Term Investments 90.3 62.8 12.2 34.2 0 0 0 15.0 36.9 7.2 0.5 0.8
Other Long Term Assets 3.1 3.9 (0.6) 3.6 4.5 4.8 0.3 0.3 (35.4) (5.5) 10 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 220.3 197.4 254.6 251.2 70.8 98.3 275.6 243.5 176.1 94.1 17.4 14.2
LIABILITIES
Accounts Payable 4.7 8.9 10.4 10.0 5.3 9.9 11.7 7.8 2.8 0.8 1.3 0.4
Short Term Debt 0 0.4 1.4 1.4 1.2 1.3 0.1 0.1 0 0 0 0
Other Current Liabilities 23.0 21.6 10.2 11.6 8.4 11.2 15.5 4.8 3.4 0.7 0.2 14 K
Total Current Liabilities 31.6 31.0 21.9 22.9 14.9 22.4 27.3 12.8 6.2 1.6 1.5 0.4
Long Term Debt 0 0 0 0 10.7 0 29.9 0 0 0 0 0
Deferred Tax Income 0 0 0.4 0.4 0.4 0.5 0.5 0.5 0 0 0 0
Other Liabilities 33.2 9.3 34.7 30.6 7.2 5.4 2.6 4.9 0.4 0 36.7 23.0
Total Liabilities 64.8 40.2 57.0 53.9 33.1 28.4 60.4 18.2 6.6 1.6 38.1 23.4
EQUITY
Common Stock 1 K 1 K 1 K 1 K 0 0 0 0 0 0 0 0
Retained Earnings (902.9) (770.8) (682.3) (595.4) (504.5) (453.5) (292.2) (159.4) (90.9) (42.8) (20.7) (9.2)
Other Accumulative Comprehensive Income/Loss 97 K (0.1) (0.9) (0.2) 94 K 66 K 69 K (0.2) (0.3) (0.1) 6 K 3 K
Total Equity 155.6 157.2 197.6 197.3 37.6 69.9 215.1 225.3 169.5 92.5 (20.8) (9.2)
Total Liabilities and Equity 220.3 197.4 254.6 251.2 70.8 98.3 275.6 243.5 176.1 94.1 17.4 14.2
SHARES OUTSTANDING
Common Shares Outstanding 77.3 69.8 65.2 56.7 42.5 41.3 32.9 28.1 21.4 6.1 10.7 10.7